1047644-72-3

Usage

Uses

Used in Pharmaceutical Synthesis:
Boc-phenylalanine is used as a protecting group in the synthesis of peptides, ensuring the stability and integrity of the phenylalanine residue throughout the process. This protection is crucial for the successful formation of desired peptide structures and the prevention of unwanted side reactions.
Used in Drug Production:
As a building block, Boc-phenylalanine is employed in the production of various drugs and bioactive compounds. Its incorporation into these molecules contributes to their overall structure and function, playing a vital role in the development of new therapeutic agents.
Used in Biotechnology Applications:
Boc-phenylalanine has a wide range of applications in the biotechnology industry, where it is utilized for the development of novel bioactive compounds and the enhancement of existing ones. Its protective properties and versatility make it an essential ingredient in the creation of innovative therapeutic solutions.
Used in Research and Development:
In the field of research and development, Boc-phenylalanine serves as a valuable tool for scientists and researchers working on the design and synthesis of new pharmaceutical compounds. Its protective capabilities and structural contributions enable the exploration of new molecular pathways and the advancement of medical knowledge.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 5053-63-4 3-amino-1-phenylpropan-1-ol 
• 614-16-4 Benzoylacetonitrile 
• 136918-14-4 phthalimide 
• 257892-43-6 (+/-)-N-(tert-butoxycarbonyl)-3-amino-1-phenylpropan-1-ol 

Downstream Products

• 1386399-46-7 (3-{3-[6-(2-morpholin-4-yl-ethylamino)-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-phenylamino}-3-phenyl-propyl)-carbamic acid tert-butyl ester 
• 1386399-48-9 (3-{6-[6-(2-morpholin-4-yl-ethylamino)-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-pyridin-2-ylamino}-3-phenyl-propyl)-carbamic acid tert-butyl ester 
• 1400670-56-5 (4-{3-[6-(3-tert-butoxycarbonylamino-1-phenylpropylamino)pyridin-2-yl]imidazo[1,2-a]pyrazin-8-ylamino}cyclohexyl)carbamic acid tert-butyl ester 
• 1400670-52-1 (4-{3-[2-(3-tert-butoxycarbonylamino-1-phenylpropylamino)pyrimidin-4-yl]imidazo[1,2-a]pyrazin-8-ylamino}cyclohexyl)carbamic acid tert-butyl ester 
• 1400670-09-8 N-{3-[6-(3-amino-1-phenylpropylamino)pyridin-2-yl]imidazo[1,2-a]pyrazin-8-yl}cyclohexane-1,4-diamine hydrochloride 
• 1400670-05-4 N-{3-[2-(3-amino-1-phenylpropylamino)pyrimidin-4-yl]imidazo[1,2-a]pyrazin-8-yl}cyclohexane-1,4-diamine hydrochloride 
• 1400669-92-2 N₁-{6-[8-(4-methylpiperazin-1-yl)imidazo[1,2-a]pyrazin-3-yl]pyridin-2-yl}-1-phenylpropane-1,3-diamine hydrochloride 
• 1400669-86-4 N₁-{4-[8-(4-methylpiperazin-1-yl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-2-yl}-1-phenylpropane-1,3-diamine hydrochloride 
• 1400670-45-2 (3-{6-[8-(4-methyl-piperazin-1-yl)-imidazo[1,2-a]pyrazin-3-yl]-pyridin-2-ylamino}-3-phenyl-propyl)-carbamic acid tert-butyl ester 
• 1400670-43-0 (3-{4-[8-(4-methyl-piperazin-1-yl)-imidazo[1,2-a]pyrazin-3-yl]-pyrimidin-2-ylamino}-3-phenyl-propyl)-carbamic acid tert-butyl ester 
• 1386980-94-4 tert-butyl 3-(4-chloro-3-(2-(methylthio)-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxamido)benzamido)-3-phenylpropylcarbamate 
• 1386980-45-5 (R)-N-(5-(3-Amino-1-phenylpropylcarbamoyl)-2-chlorophenyl)-2-methoxy-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamide 
• 1386980-04-6 N-(5-(3-amino-1-phenylpropylcarbamoyl)-2-chlorophenyl)-2-(3-(4-methylpiperazin-1-yl)propylamino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamide 
• 1386399-51-4 (4-{3-[3-(3-tert-butoxycarbonylamino-1-phenyl-propylamino)-phenyl]-1-trityl-1H-pyrazolo[3,4-d]pyrimidin-6-ylamino}-cyclohexyl)-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

CARBOXYLIC ACID ARYL AMIDES

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer.

PYRAZOLO PYRIMIDINES

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.

PYRIDO PYRIMIDINES

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.

1,6- AND 1,8-NAPHTHYRIDINES

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.

IMIDAZO PYRAZINES

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositio

PYRAZOLO PYRIMIDINES AS DYRK1A AND DYRK1B INHIBITORS

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.